Skip To Main Content
CRCG
Search Toggle
Toggle Menu
menu toggle
About
Back
Team
Faculty
Contact Us
About
Education and Training
Research and Capabilities
Back
Research Projects
Expert Committees
Funding and Other Opportunities
Equipment and Facilities
Research and Capabilities
GDUFA Research Outcomes
Back
Search
Advanced Search
Browse Outcomes
GDUFA Research Outcomes
Collaboration and Resources
Back
Collaborate on Complex Generics Research
Speak or Become a Panelist at our Events
Talk to us About Challenges
Additional Resources
Collaboration and Resources
CRCG
Resources
About
About
Team
Faculty
Contact Us
Education and Training
Research and Capabilities
Research and Capabilities
Research Projects
Expert Committees
Funding and Other Opportunities
Equipment and Facilities
GDUFA Research Outcomes
GDUFA Research Outcomes
Search
Advanced Search
Browse Outcomes
Collaboration and Resources
Collaboration and Resources
Collaborate on Complex Generics Research
Speak or Become a Panelist at our Events
Talk to us About Challenges
Additional Resources
Search Toggle
About
Team
Faculty
Contact Us
About
Education and Training
Research and Capabilities
Research Projects
Expert Committees
Funding and Other Opportunities
Equipment and Facilities
Research and Capabilities
GDUFA Research Outcomes
Search
Advanced Search
Browse Outcomes
GDUFA Research Outcomes
Collaboration and Resources
Collaborate on Complex Generics Research
Speak or Become a Panelist at our Events
Talk to us About Challenges
Additional Resources
Collaboration and Resources
Search
Search
Reset Search
Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products
Home
GDUFA Research Outcomes
Browse Outcomes
Explore This Section
GDUFA Research Outcomes
Search
Advanced Search
Browse Outcomes
Browse Research Outcomes
Author/s:
Witzmann, Kimberly
Date:
07/12/2005
Journal:
Pharmaceutical Medicine
DOI:
10.1007/s40290-020-00327-y
Download
Share
Share on Twitter
Email
linkedin
print